Health and Fitness Health and Fitness
Tue, August 4, 2009
[ Tue, Aug 04th 2009 ] - Market Wire
Oncothyreon announces commitments to purchase $15 .. mpany securities in a registered direct financing
[ Tue, Aug 04th 2009 ] - Market Wire
Stellar Pharmaceuticals Inc.: Stellar Pharmaceuti .. Host Second Quarter 2009 Earnings Conference Call
[ Tue, Aug 04th 2009 ] - Market Wire
IDenta Corp.: International Drug & Explosives Det .. IDenta Corp. Releases Update on Retail Marketing
[ Tue, Aug 04th 2009 ] - Market Wire
Angiotech Pharmaceuticals announces launch of Qui .. duct codes for laparoscopic gynecology procedures
[ Tue, Aug 04th 2009 ] - Market Wire
ImmuCell Corporation: ImmuCell Announces Financial Results for Second Quarter of 2009
[ Tue, Aug 04th 2009 ] - Market Wire
Chembio Diagnostics, Inc.: Chembio to Host Confer .. to Discuss Second Quarter 2009 Financial Results
[ Tue, Aug 04th 2009 ] - Market Wire
Crucell N.V.: Crucell to Release Q2 2009 Results on Tuesday August 11, 2009
[ Tue, Aug 04th 2009 ] - Market Wire
Constellation Software Inc.: Constellation Softwa .. rise and the Homebuilder Web Development Group As
[ Tue, Aug 04th 2009 ] - Market Wire
Oncothyreon appoints Diana Hausman as Vice President of Clinical Development
[ Tue, Aug 04th 2009 ] - Market Wire
Electro-Optical Sciences, Inc.: FDA Accepts Elect .. (R) Pre-Market Approval (PMA) Application for Rev
[ Tue, Aug 04th 2009 ] - Market Wire
Allied Healthcare: Allied Healthcare International Inc. Reports Fiscal 2009 Third Quarter Results
[ Tue, Aug 04th 2009 ] - Market Wire
Reflect Scientific: U.S. Army Awards $300,000 Contract to Reflect Scientific
Mon, August 3, 2009
[ Mon, Aug 03rd 2009 ] - Market Wire
TLC Vision Corporation: TLCVision Secures Extensi .. edit Facility Limited Waiver to September 9, 2009
[ Mon, Aug 03rd 2009 ] - Market Wire
Facet Biotech: Facet Biotech Announces Daclizumab Program in Multiple Sclerosis to Advance
[ Mon, Aug 03rd 2009 ] - Market Wire
AEterna Zentaris Partner, Keryx, Announces Agreem .. tocol Assessment for Phase 3 Trial with Perifosin
[ Mon, Aug 03rd 2009 ] - Market Wire
Syneron Medical Ltd.: Syneron Medical to Announce .. arter 2009 Financial Results on August 13th, 2009
[ Mon, Aug 03rd 2009 ] - Market Wire
AVI BioPharma, Inc.: AVI BioPharma Announces Second Quarter 2009 Financial Results Conference Call
[ Mon, Aug 03rd 2009 ] - Market Wire
MDRNA, Inc.: MDRNA, Inc. Reports Positive In Vivo .. UsiRNAs Are Highly Potent Against Metabolic and O
[ Mon, Aug 03rd 2009 ] - Market Wire
Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer
[ Mon, Aug 03rd 2009 ] - Market Wire
IDO Security, Inc.: IDO Security Announces Ray Willenberg Joins Board of Directors
Sat, August 1, 2009
[ Sat, Aug 01st 2009 ] - Market Wire
Immunotec Announces an Independent, Clinical Rese .. ospitals'; Hospital';s Community Clinical Oncolog
Fri, July 31, 2009
[ Fri, Jul 31st 2009 ] - Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Pharmace .. Capital Markets 9th Annual Focus on Healthcare C
[ Fri, Jul 31st 2009 ] - Market Wire
Immunotec Inc. announces the closing of its Korean operations
[ Fri, Jul 31st 2009 ] - Market Wire
Genomic Health: Genomic Health Delivers Online Perspective
[ Fri, Jul 31st 2009 ] - Market Wire
BioMedReports: Biotech Drug Company Preparing for .. Using Extremely Promising New Technology (NYSE A
[ Fri, Jul 31st 2009 ] - Market Wire
SemBioSys announces agreement with Avrio Ventures Limited Partnership and Botaneco
[ Fri, Jul 31st 2009 ] - Market Wire
AVI BioPharma, Inc.: AVI BioPharma, Inc. Files Shelf Registration Statement
Thu, July 30, 2009
[ Thu, Jul 30th 2009 ] - Market Wire
IDC reports second quarter 2009 results
[ Thu, Jul 30th 2009 ] - Market Wire
Dianor Resources Inc.: Dianor Announces Closing of $1,500,000 Private Placement With MineralFields
[ Thu, Jul 30th 2009 ] - Market Wire
Facet Biotech Corporation: Facet Biotech Announce .. pital Markets 9th Annual Focus on Healthcare Conf

Facet Biotech Corporation: Facet Biotech Announces Participation at the BMO Capital Markets 9th Annual Focus on Healthcare Conf


Published on 2009-07-30 13:21:31, Last Modified on 2009-07-30 13:21:39 - Market Wire
  Print publication without navigation


REDWOOD CITY, CA--(Marketwire - July 30, 2009) - Facet Biotech Corporation (NASDAQ: [ FACT ]) today announced that the company will participate at the upcoming BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York on Wednesday, August 5, 2009 at 8:30 a.m., Eastern Time.

A live webcast of the presentation and the Q&A session will be available through the Facet website at [ www.facetbiotech.com ]. Please connect to this website at least 15 minutes prior to the live webcast to allow time for any software download that may be needed to hear the webcast. A replay will be available at [ www.facetbiotech.com ] starting approximately one hour after completion of the webcast.

About Facet Biotech

Facet Biotech is a biotechnology company dedicated to advancing its pipeline of four clinical-stage products, leveraging its research and development capabilities to identify and develop new oncology drugs and applying its proprietary next-generation protein engineering technologies to potentially improve the clinical performance of protein therapeutics. Facet Biotech Corporation launched in December 2008 as a spin-off from PDL BioPharma, Inc.

NOTE: Facet Biotech and the Facet Biotech logo are considered trademarks of Facet Biotech Corporation.

Contributing Sources